Here we discuss cancer- the disease. Especially useful for oncology residents.
For feedback mail : oncopodindia@gmail.com
Follow on instagram: https://instagram.com/oncopodindia?r=nametag
Cancer ke numbers ka sach: Real Progress or illusion???
Cancer ke baare mein jab hum numbers sunte hain—
survival rate, percentage, statistics—
toh aksar darr badh jaata hai.
Is episode mein OncoPODindia par hum simple Hindi/Hinglish mein samjhaate hain:
5-year survival ka matlab kya hota hai
Yeh numbers aapke future ko decide kyun nahi karte
Kaise cancer survival aaj pehle se kaafi better ho chuki hai
Aaj science ke data ke hisaab se:
Har 10 mein se lagbhag 7 cancer patients 5 saal ya usse zyada jee rahe hain
Advanced cancers jaise lung cancer, rectal cancer, melanoma, aur blood cancers mein survival rates 1990s ke mukable double ho chuke hain
Yeh episode numbers se darr paida karne ke liye nahi—
numbers ko sahi context mein samajhne ke liye hai.
🎙️ Hosted by Dr. Faraz Badar, Radiation Oncologist
📊 Data based on large international cancer studies, including the American Cancer Society
Message simple hai:
Cancer aaj pehle jaisa nahi raha—
aur aaj ki umeed science par based hai.
Cancer Awareness, Cancer Survival, Cancer Statistics, 5 Year Survival, Oncology, Hindi Health Podcast, Cancer Education, Indian Cancer Podcast, OncoPODindia, Cancer Hope, Radiation Oncology, Health Awareness India
14 Jan 2026
Cancer Today: How Science Is Quietly Saving Lives
Cancer is no longer the diagnosis it once was.
In this short episode of OncoPODindia, we share encouraging, science-backed insights showing how modern medicine has transformed cancer care. Today, nearly 70% of people diagnosed with cancer are alive five years later, and survival has improved dramatically—even for advanced-stage cancers.
From targeted therapies to immunotherapy and precision medicine, science is helping patients live longer and better lives.
This episode is for patients, families, and anyone who believes that early diagnosis, timely treatment, and trust in science can change outcomes.
🎙️ Hosted by Dr. Faraz Badar, Radiation Oncologist
📌 OncoPODindia – bringing clarity, compassion, and credible cancer information
31 Jan 2023
Molecular classification of MEDULLOBLASTOMA and its clinical implications
Molecular classification of medulloblastoma is now firmly in place. In this episode the 4 key subtypes that is
WNT ACTIVATED
SHH ACTIVATED (p53 mutant and wild type)
GROUP 3
GROUP 4
are discussed with an emphasis on how these differ from each other. Also you will get to know what additional information this molecular classification will give to clinicians. If you are more of an instagrammer you may like to visit the instagram page where this topic has been presented in text format.
Here is the link to instagram profile: https://www.instagram.com/oncopodindia/
please share your feedback on oncopodindia@gmail.com
20 Dec 2022
TRAMADOL vs TAPENTADOL: COMPARATIVE DRUG REVIEW
Pain is one of the most common symptom experienced by cancer patients. While we have a lot of drugs to treat cancer pain, opioids lead the way in treating moderate to severe pain. Tramadol and tapentadol are two opioid drugs. In this comparative review key similarities and differences are discussed.
Feedback is welcome.
Write to us at oncopodindia@gmail.com
17 Nov 2022
ENDOMETRIAL CANCER: TYPE I vs TYPE II
Endometrial cancer is the most common gynaecological cancer in developed countries. In this episode of OncoPODindia, the traditional dualistic classification (Type I vs Type II endometrial cancer) is discussed. Although the cancer genome atlas has come up with new molecular classification of endometrial cancer, still the older traditional classification remains very important. This comparative analysis is a part of PROJECT VERSUS where complex topics are presented in a comparative manner so as to make them easy to understand.
Feedbacks are welcome and eagerly awaited.
Please follow us on instagram ( OncoPODindia ) where these differences have been put in infographics format.
You can also mail us on oncopodindia@gmail.com
2 Nov 2022
VINKA ALKALOIDS vs TAXANES
Comparison between two very important class of chemotherapy drugs i.e. Vinka Alkaloids and taxanes.
26 Oct 2022
PEDIATRIC vs ADULT MEDULLOBLASTOMA
In this episode, key differences between childhood and adult medulloblastoma is enumerated
26 Oct 2022
OncoPODindia (Trailer)
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Spotify
5.0 / 5
5 ratings
Contact OncoPODindia
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of OncoPODindia?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
